AMRI 4th quarter total income increases 12 percent to $48 generictadalafil.net .6 million AMRI today reported financial and operating outcomes for the fourth one fourth and full year ended December 31, 2010. Financial highlights for the 4th quarter and other recent announcements include: Contract income growth of 16 percent over 4th quarter 2009 including 48 percent growth in Large Scale Manufacturing Contract revenue development of 12 percent over 4th quarter 2009 in Advancement/Small Scale, the 1st quarter of growth since the fourth quarter of 2008 117 percent organic development in Discovery and Development/Small Scale functions in Asia A research and licensing contract with Genentech, Inc.